semaglutide and ibd versus placebo in individuals with poor weight loss after bariatric surgery: a double-blinded, randomized, placebo-controlled trial Semaglutide and Ulcerative Colitis: Safety

T., & Ciriolo, M

Semaglutide's mechanism of slowing gastric emptying and its common gastrointestinal side effectsincluding nausea, vomiting, diarrhea, and abdominal painoverlap significantly with UC symptoms

Patients experiencing this may prefer evening administration to avoid daytime lethargy affecting work or daily activities

Your PlexusDx provider can discuss which option fits your medical history

If you're considering franchise ownership, we're eager to connect with you and explore opportunities to collaborate in advancing the health and wellness of individuals across the country

We'll update your file and add the approved names